SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AMLN (DIABETES DRUGS) -- Ignore unavailable to you. Want to Upgrade?

To: David Bogdanoff who wrote (1301)4/6/1998 2:39:00 PM
From: D.Right  Read Replies (1) | Respond to of 2173
 
Exactly, David. That is a good post.



To: David Bogdanoff who wrote (1301)4/6/1998 8:55:00 PM
From: Cacaito  Respond to of 2173
 
David, Amln said four ongoing studies were modified for the insulin adjustment. I am not referring to new studies.

These modifications were announced at the time of the report of the completed phase III studies last year.



HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News